Pradžia › Glioma › Masčusetsas
Glioma klinikiniai tyrimai Masčusetsas
20 tyrimai dėl Glioma ieško dalyvių vietose Masčusetsas.
Miestai Masčusetsas
Oficialus tyrimo tekstas (anglų kalba)
MCT for the Harvard/UCSF ROBIN Center
- Brigham and Women's Hospital, Boston
Renkami dalyviai
Visi amžiai · Visoms lytims · Atnaujinta 2026-10-01 · NCT06000787A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Dana-Farber Cancer Institute, Boston
Renkami dalyviai1/2 fazė
12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-10-01 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07326566A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Dana Farber Cancer Institute., Boston
Renkami dalyviai1/2 fazė
Iki 25 metų · Visoms lytims · Atnaujinta 2026-09-25 · NCT04094610Targeted Pediatric High-Grade Glioma Therapy
- Dana-Farber Cancer Institute, Boston
Renkami dalyviaiStebimasis tyrimas
12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-09-08 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Susan Chi, Boston
Renkami dalyviai2 fazė
Amžius nuo 12 iki 39 · Visoms lytims · Atnaujinta 2026-09-01 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Dana-Farber Cancer Institute, Boston
Renkami dalyviai2 fazė
Amžius nuo 3 iki 39 · Visoms lytims · Atnaujinta 2026-08-24 · NCT05096481Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Boston
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-08-12 · NCT05417594A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Renkami dalyviai2 fazė
Amžius 8 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT05503797CARv3-TEAM-E T Cells in Glioblastoma
- Massachusetts General Hospital Cancer Center, Boston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-14 · NCT05660369Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Dana-Farber Cancer Institute, Boston
Renkami dalyviaiAnkstyvoji 1 fazėLaukiami sveiki savanoriai
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2026-06-29 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Dana-Farber Cancer Institute, Boston
Renkami dalyviai2 fazė
12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-05-29 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Dana Farber Cancer Institute, Boston
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-13 · NCT06810544A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Dana-Farber Cancer Institute, Boston
Renkami dalyviaiAnkstyvoji 1 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2026-03-18 · NCT04655404rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
Renkami dalyviai1 fazė
12 Months – 18 Years · Visoms lytims · Atnaujinta 2026-03-17 · NCT04943848CUE-102 in Recurrent Glioblastoma
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-05 · NCT06917885NeuroPathways Intervention for Brain Tumor Patients
- Massachusetts General Hospital Cancer Center, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-12-17 · NCT05976490ASCENT Intervention for Brain Tumor Patients
- Massachusetts General Hospital Cancer Center, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-07-14 · NCT06099743The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- Massachusetts General Hospital, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2024-02-22 · NCT06118723Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.